20 years of work yields a compound that blocks a new Alzheimer's target and extends lifespan in mice
A new compound slowed brain-cell death and extended lifespan in mice by blocking GRK2, an enzyme behind Alzheimer's that existing drugs don't target, ETH Zurich scientists found.
Peer-reviewed · Cell Reports Medicine / ETH Zurich · 12 June 2026